Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nasal cavity, paranasal sinuses, orbita and anterior skull base Moderator: Jeffrey Myers MD PhD Professor and Deputy Chair for Research Department of Head.

Published byKelvin Heydon Modified over 9 years ago

Similar presentations

Presentation on theme: "Nasal cavity, paranasal sinuses, orbita and anterior skull base Moderator: Jeffrey Myers MD PhD Professor and Deputy Chair for Research Department of Head."— Presentation transcript:

1 Nasal cavity, paranasal sinuses, orbita and anterior skull base Moderator: Jeffrey Myers MD PhD Professor and Deputy Chair for Research Department of Head and Neck Surgery University of Texas, M.D. Anderson Cancer Center

2 Lecturer: Friedrich Bootz M. D. Chair for Otorhinolaryngology and Director of Department of Otorhinolaryngology University of Bonn. Panelists: Alexis Rapidis, D.D.S., M.D., Ph.D. Professor of Surgery Greek Anticancer Institute Athens, Greece Volker Seifert, M.D., Ph.D. Professor and Chairman Department of Neurosurgery Johan Wolfgang Goethe- University Frankfurt am Main Claus Rödel MD Director of the Department of Radiotherapy and Oncology Johann Wolfgang Goethe-University Frankfurt am Main

3 Role of Non-Surgical Therapy Role of Induction Chemotherapy Role of Chemoradiotherapy Role of Radiotherapy

4 Role of Surgery For Primary Therapy For Salvage Approaches –Open –Endoscopic

5 C.D. 48 yo male with SCC

6 M.K. 74 yo female with SNUC

7 J. N. 44 yo female with ACC

8 Outcomes in Patients with Adenoid Cystic Carcinoma of the Lacrimal Gland 20pts 6M:14F Mean age 39.5yrs Median follow-up 34 months (6-264mos) Treatment –Exent+XRT 8Pts –Orbitectomy+XRT 5 –Exent 1 –Orbitectomy 1 –Enucleation+XRT 3 –Enucleation 2 Esmaeli et al Ophthal Plast Reconstr Surg. 2004

9 Outcomes in Patients with Adenoid Cystic Carcinoma of the Lacrimal Gland Local recurrence 7Pts (35%) Distant Mets 16Pts (80%) Dead of disease13Pts (65%) Median survival18 Months Esmaeli et al Ophthal Plast Reconstr Surg. 2004

10 A.K. 21yo male with Osteogenic Sarcoma 22 yearsMale 22 yearsMale

Download ppt "Nasal cavity, paranasal sinuses, orbita and anterior skull base Moderator: Jeffrey Myers MD PhD Professor and Deputy Chair for Research Department of Head."

Similar presentations

Ismail Jatoi, MD, PhD, FACS Dale H. Dorn Chair in Surgery Professor and Chief, Division of Surgical Oncology University of Texas Health Science Center.

Ismail Jatoi, MD, PhD, FACS Dale H. Dorn Chair in Surgery Professor and Chief, Division of Surgical Oncology University of Texas Health Science Center.
Neoadjuvant Chemotherapy in Locally Advanced Squamous Cell Cancer of Head and Neck Mei Tang, MD.

Neoadjuvant Chemotherapy in Locally Advanced Squamous Cell Cancer of Head and Neck Mei Tang, MD.
CARBON ION THERAPY FOR SACRAL CHORDOMAS

CARBON ION THERAPY FOR SACRAL CHORDOMAS
Danny Indelicato, MD CTOS 2012 Ewing Sarcoma of the Axial Skeleton: Early Outcomes from the University of Florida Proton Therapy Program.

Danny Indelicato, MD CTOS 2012 Ewing Sarcoma of the Axial Skeleton: Early Outcomes from the University of Florida Proton Therapy Program.
Neck Cancer Head and STATEMENTS ON January 28, 2006 Frankfurt am Main, Germany Surgery Surgery in Multimodal Treatment.

Neck Cancer Head and STATEMENTS ON January 28, 2006 Frankfurt am Main, Germany Surgery Surgery in Multimodal Treatment.
Age as a prognostic factor for head and neck squamous cell carcinoma: should older patients be treated differently? Udi Cinamon 1, Michael P. Hier 2, Martin.

Age as a prognostic factor for head and neck squamous cell carcinoma: should older patients be treated differently? Udi Cinamon 1, Michael P. Hier 2, Martin.
Neoadjuvant Chemotherapy in Malignant Peripheral Nerve Sheath Tumors Elizabeth Shurell, M.D., M.Phil. UCLA General Surgery Resident Research Fellow, Division.

Neoadjuvant Chemotherapy in Malignant Peripheral Nerve Sheath Tumors Elizabeth Shurell, M.D., M.Phil. UCLA General Surgery Resident Research Fellow, Division.
Yao 1 Neuroendocrine Tumors James C. Yao, MD Associate Professor Deputy Chairman, Gastrointestinal Medical Oncology University of Texas M. D. Anderson.

Yao 1 Neuroendocrine Tumors James C. Yao, MD Associate Professor Deputy Chairman, Gastrointestinal Medical Oncology University of Texas M. D. Anderson.
Value of local treatment in extrapulmonary metastatic Ewing sarcoma

Value of local treatment in extrapulmonary metastatic Ewing sarcoma
H. AlHussain, I. Busca, L. Eapen,, S. El-Sayed The Ottawa Hospital Cancer Center, University of Ottawa Department of Radiation Oncology.

H. AlHussain, I. Busca, L. Eapen,, S. El-Sayed The Ottawa Hospital Cancer Center, University of Ottawa Department of Radiation Oncology.
Surgical Management of Oropharyngeal Cancers Kerry D. Olsen, M.D. Professor, Otolaryngology Head and Neck Surgery Mayo Clinic Kerry D. Olsen, M.D. Professor,

Surgical Management of Oropharyngeal Cancers Kerry D. Olsen, M.D. Professor, Otolaryngology Head and Neck Surgery Mayo Clinic Kerry D. Olsen, M.D. Professor,
Joint Hospital Surgical Grand Round KL FOK NDH/AHNH Department of Surgery.

Joint Hospital Surgical Grand Round KL FOK NDH/AHNH Department of Surgery.
V. Budach – Statements on H&N Cancer - 1 Discussion Panel on Primary Radiochemotherapy Volker Budach, MD, PhD Head Department for Radiation Oncology Charité.

V. Budach – Statements on H&N Cancer - 1 Discussion Panel on Primary Radiochemotherapy Volker Budach, MD, PhD Head Department for Radiation Oncology Charité.
Neck Cancer Head and STATEMENTS ON January 28, 2006 Frankfurt am Main, Germany Surgery Laser Surgery.

Neck Cancer Head and STATEMENTS ON January 28, 2006 Frankfurt am Main, Germany Surgery Laser Surgery.
Indications for adjuvant radiation therapy with or without lymph nodes in salivary gland cancer Claus Rödel Department of Radiation Therapy University.

Indications for adjuvant radiation therapy with or without lymph nodes in salivary gland cancer Claus Rödel Department of Radiation Therapy University.
Surgical resection of metastatic GIST on imatinib delays recurrence and death: results of a cross- match comparison in the EORTC Intergroup 62005 study.

Surgical resection of metastatic GIST on imatinib delays recurrence and death: results of a cross- match comparison in the EORTC Intergroup study.
Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.

Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.
Breast Cancer: Follow up and Management of recurrence Carol Marquez, M.D. Associate Professor Department of Radiation Medicine OHSU.

Breast Cancer: Follow up and Management of recurrence Carol Marquez, M.D. Associate Professor Department of Radiation Medicine OHSU.
Thomas F. DeLaney MD, Aashish D. Bhatt MD, Alex Jacobson BS, Richard Y. Lee MD, PhD, Christine Giraud BS, Joseph H. Schwab MD, MS, Francis J. Hornicek.

Thomas F. DeLaney MD, Aashish D. Bhatt MD, Alex Jacobson BS, Richard Y. Lee MD, PhD, Christine Giraud BS, Joseph H. Schwab MD, MS, Francis J. Hornicek.
Controversies in the management of PSA-only recurrent disease Stephen J. Freedland, MD Associate Professor of Urology and Pathology Durham VA Medical Center.

Controversies in the management of PSA-only recurrent disease Stephen J. Freedland, MD Associate Professor of Urology and Pathology Durham VA Medical Center.

Similar presentations

Ads by Google